Achieve Life Sciences presents long-term cytisinicline data

Achieve Life Sciences has announced the presentation of long-term data regarding cytisinicline, a smoking cessation treatment. The data highlights the efficacy and safety of cytisinicline over an extended period, contributing to the growing body of research on its potential benefits for individuals seeking to quit smoking. This presentation is part of the company's ongoing efforts to provide comprehensive information on the therapeutic applications of cytisinicline. Further details on the study's methodology and results were shared during the announcement.

Read More